The role of manufacturing in improving cell immunotherapies

Phacilitate | 11 Feb 2026
Excellos specializes in deep characterization of starting materials for adaptive immunotherapies for the better cellular immunotherapies as well as being flexibility in novel process development.
View all ATW26 Content
Loading